Phase I BP Interferon (IFN) Beta-001

NCT02515695 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: Interferon beta-1a

Sponsor

Centre Hospitalier Universitaire Vaudois

Collaborators

[object Object]